Assisted Reproductive Technology Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Assisted Reproductive Technology Market size was worth USD 33.4 billion in 2026 and is expected to grow at a 5.7% CAGR between 2027 and 2036, crossing USD 58.14 billion by 2036. The industry revenue for 2027 is estimated at USD 35 billion.
Get more details on this report
Request Free Sample ReportAssisted Reproductive Technology Market Intelligence Snapshot
Regional Market Dynamics
- Europe led the market in 2026 with established fertility clinic networks, advanced reproductive procedures, and mature clinical pathways supporting consistent treatment volumes and patient access.
- North America is projected to grow at a 7.01% CAGR as demand rises for advanced fertility services, supported by private fertility providers and increasing adoption of sophisticated laboratory techniques.
Segment Momentum
- IVF leads with an 87.31% share due to its established clinical role, broader applicability across fertility cases, and strong physician reliance on its controlled and repeatable treatment pathway.
- Hospital and surgery clinics are expanding fastest as fertility services integrate into broader healthcare systems, improving patient access through existing hospital networks and diversified clinical infrastructure.
Market Expansion Drivers
- Rising global infertility prevalence increasing demand for assisted reproductive procedures and fertility services.
- Advancements in embryo testing and imaging technologies improving ART success rates.
- Growing public awareness and fertility clinic expansion supporting wider acceptance of reproductive treatments.
Leading Market Participants
- Top companies in the assisted reproductive technology market include CooperSurgical, Inc. (United States), Merck KGaA (Germany), Ferring Pharmaceuticals (Switzerland), Vitrolife AB (Sweden), Irvine Scientific Sales Company, Inc. (United States), Hamilton Thorne Ltd. (Canada), FUJIFILM Irvine Scientific, Inc. (United States), Genea Biomedx Pty Ltd. (Australia), Cook Medical LLC (United States), Esco Micro Pte. Ltd. (Singapore).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 33.4 billion
- 2027 Estimated Market Size: USD 35 billion.
- Projected Market Size: USD 58.14 billion by 2036
- Growth Forecast: 5.7% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Europe
- High-Growth Regional Hub: North America
- Core Revenue Segment: In-Vitro Fertilization (IVF) (Type) | Fertility Clinics (End-use)
- Emerging Opportunity Segment: Artificial Insemination (Type) | Hospital & Surgery Clinics (End-use)
Market Growth Drivers and Industry Trends
Rising global infertility prevalence increasing demand for assisted reproductive procedures and fertility services
The increasing prevalence of infertility among individuals and couples is strengthening demand for medical interventions, which will propel the assisted reproductive technology market. Changes in reproductive health patterns, delayed family formation, and the growing need for specialized fertility care are encouraging more patients to seek clinical assistance when natural conception is difficult. Procedures such as in vitro fertilization and related fertility treatments provide structured pathways for patients requiring reproductive support, increasing utilization of fertility clinics and associated laboratory services. The need for personalized treatment planning and repeated clinical interventions also contributes to sustained demand for reproductive technologies, diagnostic services, and specialized fertility care.
Advancements in embryo testing and imaging technologies improving ART success rates
Technological improvements in embryo assessment, testing, imaging, and laboratory procedures are enhancing treatment selection and decision-making, supporting growth of the assisted reproductive technology market. More sophisticated approaches to evaluating embryo development can provide fertility specialists with additional information when determining which embryos are appropriate for transfer. Advanced imaging capabilities can also support closer observation of embryonic development during laboratory procedures, helping clinicians assess developmental characteristics with greater precision. These improvements can increase confidence in treatment protocols and encourage patients and healthcare providers to adopt technologically advanced fertility procedures as part of comprehensive reproductive care.
Growing public awareness and fertility clinic expansion supporting wider acceptance of reproductive treatments
Greater awareness of infertility treatment options is reducing information barriers and encouraging more individuals to explore professional fertility services, thereby supporting the assisted reproductive technology market. Increased access to educational resources and broader discussion of reproductive health are helping patients become more familiar with available procedures, treatment pathways, and fertility preservation options. At the same time, the expansion of fertility clinics and specialized reproductive care facilities is improving access to assisted reproductive procedures across more patient populations. A wider clinical footprint enables patients to obtain consultations, diagnostic assessments, laboratory services, and treatment within dedicated reproductive healthcare settings.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global infertility prevalence increasing demand for assisted reproductive procedures and fertility services | 2.00% | High | Europe, North America | High | Near Term |
| Advancements in embryo testing and imaging technologies improving ART success rates | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Growing public awareness and fertility clinic expansion supporting wider acceptance of reproductive treatments | 1.50% | Moderate | Asia Pacific, Europe | Medium | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
Europe (Largest Region)
Europe led the assisted reproductive technology market in 2026, supported by established fertility-care infrastructure, widespread access to reproductive health services, and substantial clinical expertise in assisted conception procedures. The region has a mature network of fertility centers and specialized healthcare professionals, while advancements in embryo assessment, cryopreservation, and laboratory technologies continue to improve treatment capabilities. Growing acceptance of fertility treatment, delayed parenthood, and increasing awareness of available reproductive options are also supporting demand. In addition, established clinical standards and regulatory frameworks contribute to treatment quality and patient confidence, reinforcing Europe's position as a major market for assisted reproductive technologies.
North America (Fastest-Growing Region)
North America is the fastest-growing region, benefiting from rising demand for fertility services, technological advancement, and increasing investment in specialized reproductive healthcare. Greater awareness of fertility preservation and assisted conception is encouraging more individuals and couples to seek treatment, while improvements in laboratory techniques and reproductive diagnostics are broadening available treatment options. The region's strong private healthcare infrastructure and access to advanced medical technologies further support adoption. Increasing interest in personalized fertility care, together with greater integration of digital tools and advanced clinical workflows, is creating additional opportunities for market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Regulated Clinical PracticeGermany's assisted reproductive technology market operates within a structured regulatory framework that shapes treatment approaches and laboratory standards. Fertility providers in Germany focus on clinical quality, patient safety, and specialized reproductive care services.
France 🇫🇷
Integrated Fertility CareFrance prioritizes coordinated reproductive healthcare with strong clinical oversight and standardized fertility services. Fertility centers in France continue enhancing laboratory quality and multidisciplinary care to support patients throughout the treatment journey.
Italy 🇮🇹
Specialized Clinical NetworksItaly continues expanding specialized fertility centers with greater emphasis on advanced reproductive procedures and laboratory expertise. Italian providers focus on improving treatment accessibility, embryo preservation technologies, and coordinated patient care.
Japan 🇯🇵
Aging Population ResponseJapan continues strengthening assisted reproductive technology services to address delayed parenthood and changing demographic trends. Fertility centers in Japan invest in laboratory modernization, cryopreservation capabilities, and patient-centered reproductive care.
South Korea 🇰🇷
Advanced Fertility ServicesSouth Korea supports assisted reproductive technology through technologically advanced fertility clinics and expanding reproductive health services. Providers in South Korea increasingly integrate digital monitoring and laboratory automation to enhance treatment efficiency and patient engagement.
United States 🇺🇸
Innovation-Driven TreatmentThe U.S. assisted reproductive technology market emphasizes advanced fertility procedures, genetic screening, and digital patient management. Clinics across the U.S. continue expanding personalized treatment pathways and laboratory capabilities to improve patient experience and clinical efficiency.
Segment Leadership and Growth Trends
Assisted Reproductive Technology Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: In-Vitro Fertilization (IVF) (Largest Segment) vs Artificial Insemination (Fastest-Growing Segment)
The in-vitro fertilization (IVF) segment dominated the assisted reproductive technology market in 2026, accounting for an 87.31% share, reflecting its established role in treating a broad range of infertility challenges and its ability to support more complex reproductive needs. IVF enables controlled fertilization and embryo development before transfer, making it a widely utilized option when conventional approaches are insufficient or when multiple reproductive factors require clinical intervention. Artificial insemination is expanding at the fastest pace as patients and healthcare providers increasingly seek less complex and comparatively accessible fertility treatment options where clinically appropriate. Growing awareness of fertility services, broader access to reproductive care, and increasing demand for personalized treatment pathways are supporting wider consideration of artificial insemination.
End-use Segment Analysis: Fertility Clinics (Largest Segment) vs Hospital & Surgery Clinics (Fastest-Growing Segment)
Fertility clinics held the leading position in the assisted reproductive technology market in 2026 with a 76.73% share, owing to their specialized infrastructure, dedicated reproductive medicine expertise, and ability to provide comprehensive fertility assessment and treatment services. These facilities are structured around the specific clinical, laboratory, and procedural requirements associated with assisted reproduction, supporting efficient delivery of complex fertility care. Hospital & surgery clinics are experiencing the fastest growth as reproductive services become increasingly integrated into broader healthcare systems and patients seek fertility treatment within multidisciplinary medical environments. Greater access to specialized reproductive procedures, improved hospital-based fertility capabilities, and the integration of reproductive care with related medical services are supporting expansion across this end-use setting.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | In-Vitro Fertilization (IVF), Artificial Insemination | In-Vitro Fertilization (IVF) | Artificial Insemination |
| End-use | Fertility Clinics, Hospital & Surgery Clinics | Fertility Clinics | Hospital & Surgery Clinics |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the assisted reproductive technology market:
1. CooperSurgical Inc. (United States)
2. Merck KGaA (Germany)
3. Ferring Pharmaceuticals (Switzerland)
4. Vitrolife AB (Sweden)
5. Irvine Scientific Sales Company Inc. (United States)
6. Hamilton Thorne Ltd. (Canada)
7. FUJIFILM Irvine Scientific Inc. (United States)
8. Genea Biomedx Pty Ltd. (Australia)
9. Cook Medical LLC (United States)
10. Esco Micro Pte. Ltd. (Singapore)
Advancements in reproductive science are enabling more precise and effective fertility treatment approaches. Increasing collaboration between clinical research and diagnostic innovation is improving success rates and procedural efficiency. The assisted reproductive technology market is evolving through enhanced genetic screening and embryo assessment techniques.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| CooperSurgical Inc. (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| Ferring Pharmaceuticals (Switzerland) | |||||||
| Vitrolife AB (Sweden) | |||||||
| Irvine Scientific Sales Company Inc. (United States) | |||||||
| Hamilton Thorne Ltd. (Canada) | |||||||
| FUJIFILM Irvine Scientific Inc. (United States) | |||||||
| Genea Biomedx Pty Ltd. (Australia) | |||||||
| Cook Medical LLC (United States) | |||||||
| Esco Micro Pte. Ltd. (Singapore). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| ATBUTH | May-26 | The Abubakar Tafawa Balewa University Teaching Hospital (ATBUTH) commissioned a new specialized Infertility and Assisted Reproductive Technology Centre. This public-sector investment significantly expands regional healthcare capacity, establishing a dedicated facility for advanced infertility diagnostics and reproductive medicine that strengthens the institutional footprint of ART services within Nigeria's healthcare landscape. |
| RSCM Kencana | May-26 | Dr. Cipto Mangunkusumo National Hospital (RSCM) relaunched its Klinik Yasmin Reproductive Cluster through RSCM Kencana. This initiative optimizes integrated reproductive care by streamlining clinical pathways and combining ART services with multi-disciplinary clinical support, aimed at enhancing operational efficiency and patient throughput within Indonesia’s primary public hospital network. |
| Yangon Fertility Centre | May-26 | The Yangon Fertility Centre at Central Women’s Hospital reported sustained operational growth, having supported over 5,400 women since its inception. The continued expansion of service utilization within this public-sector facility indicates a meaningful rise in demand for fertility treatments in Myanmar and highlights the scaling of public health infrastructure for reproductive medicine. |
| Costco | Mar-26 | Costco initiated a strategic partnership with healthcare providers to address cost barriers associated with fertility treatments. By integrating employer-linked or membership-based health solutions, the initiative aims to increase patient access to expensive procedures such as IVF across the United States, effectively introducing new commercial pathways for service delivery within the reproductive care sector. |
| Yellow Fertility | Jan-26 | Yellow Fertility entered a strategic partnership with CARE IVF to scale fertility treatment infrastructure across Eastern and North-Eastern India. The expansion plan includes the establishment of eight new fertility centers over a two-year period, focusing on standardizing clinical protocols and increasing regional accessibility to high-quality IVF services in previously underserved markets. |
| Fresenius Kabi | Aug-24 | Fresenius Kabi launched a generic version of cetrorelix acetate injection, a critical pharmaceutical agent used in controlled ovarian stimulation protocols. By introducing a lower-cost alternative to established therapies, the company is facilitating broader affordability for IVF treatment regimens, directly impacting the cost structure and accessibility of essential ART-related medical interventions. |
| Cook Medical | Jul-24 | Cook Medical entered a definitive agreement to divest its reproductive health business to the private equity firm Astorg. The transaction includes plans to integrate these assets with Hamilton Thorne’s existing portfolio, signaling a strategic consolidation effort within the fertility-focused medical device market aimed at achieving greater operational scale and technical synergy. |
| Kindbody | Jan-24 | Kindbody accelerated its expansion strategy by scaling its clinic network and enhancing its digital-first fertility care model. This strategic growth phase focuses on leveraging technology-enabled service delivery to improve operational performance and market penetration, reinforcing the company's position as a provider of comprehensive, scalable assisted reproductive technology services. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Assisted Reproductive Technology Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Treatment Cycle Stage | Ovarian Stimulation & Monitoring, Oocyte Retrieval & Fertilization, Embryo Transfer, Cryopreservation & Frozen Embryo Transfer |
| Patient Age Group | Under 30 Years, 30–34 Years, 35–39 Years, 40 Years & Above |
| Payment Model | Self-Pay, Private Insurance, Public Funding & Government Programs |
Assisted Reproductive Technology Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Patient Journey and Service Delivery Optimization |
|
| Fertility Clinic Network Expansion Strategy |
|
| Emerging Treatment Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the assisted reproductive technology market?
What is the projected value of the assisted reproductive technology industry by 2036?
How are advances in embryo assessment technologies influencing investment in assisted reproductive technology?
Why is expanding fertility care access accelerating growth in the assisted reproductive technology market?
Why does IVF remain the dominant procedure in the assisted reproductive technology market?
What is driving faster growth of hospital and surgery clinic involvement in ART services?
Why is Europe the leading regional market for assisted reproductive technology?
What is driving assisted reproductive technology market growth in North America?
Which companies are driving growth in the assisted reproductive technology landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization